Tech entrepreneur-turned longevity evangelist Bryan Johnson, who spends millions trying to reverse his biological age, has unveiled his most exclusive experiment yet: a $1 million-a-year health program with just three slots.

In a post on X on Thursday, Johnson announced "Immortals," calling it the exact protocol he has followed for the past five years in his quest to slow aging. The offering, he said, includes a dedicated concierge team, round-the-clock AI guidance, continuous biomarker tracking, and access to what he described as the world's best therapies.

Today, we are launching Immortals. + $1,000,000 per year + Three spots available Immortals is the world's best health program. It is the exact protocol I have followed for the last 5 years. It is your Autonomous Health. Includes a dedicated concierge team,

The Price Of Not Dying

The headline number is hard to ignore: $1 million per year, fully managed.

Applicants must pass an interview process, hire a dedicated assistant, and commit significant time to the regimen. Only three people will be admitted to the top tier - at least for now.

Johnson framed the program as the world's most advanced health protocol, built around constant measurement, scientific testing, and repeated interventions - the same principles behind his own daily routine of supplements, strict diets, sleep optimization, and experimental treatments.

A Tiered Path To Longevity

While the seven-figure entry point targets the ultra-wealthy, Johnson says cheaper versions are coming.

Johnson, who sold payments firm Braintree to PayPal (PYPL  ) for $800 million, has since reinvented himself as a biohacking pioneer. He reportedly spends millions each year on an extreme anti-aging protocol that includes strict diets, dozens of supplements, biometric monitoring, and experimental treatments - all in a quest to slow or even reverse aging.

For the "Immortals" program, he outlined a $60,000 "supported" tier and a free digital version in the months ahead, arguing that costs should fall as the system scales. The long-term goal, he wrote, is universal access to the same standard of care, regardless of income.